Catalyst Wire Dossier Catalyst Wire Dossier

Autologous dendritic cell vaccine expressing MUC1

dendritic cell vaccine expressing MUC1 · Hamilton Health Sciences Corporation
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Autologous dendritic cell vaccine expressing MUC1, covering 2016-09-15 to 2016-09-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study Evaluating Vaccination of Prostate Cancer Patients With Self Dendritic Cells Expressing MUC1 [Phase 1, Phase 2]

See pricing